Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg

NCT02698384 · clinicaltrials.gov ↗
TERMINATED
Status
4
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated early due to insufficient potential for recruitment.

Conditions

Sponsor

Ipsen